Skip to content

analyst.andrewlengly.com/studies/oura-and-whoop :: oura and whoop

# Does paying for a wearable change how people live? US wearable use rose from 30.2% to 41.1% between 2020 and 2024 while the share meeting the activity guideline moved 0.1 points. A data study by Andrew Leng Ly.

designed page ......... analyst.andrewlengly.com/studies/oura-and-whoop

OURA AND WHOOP

analyst work .......... /machine/analyst
data study ............ October 2026

question .............. Does paying for a wearable change how people live?
headline finding ...... From 2020 to 2024 the share of US adults using a wearable rose from
                        30.2% to 41.1%, and the share meeting the aerobic activity guideline
                        went from 47.9% to 48.0%. Oura keeps 85% of paid members for a year.
                        I found no figure in the coverage of its IPO filing for whether
                        members sleep or move more.
my recommendation ..... Turn Advisor into a weekly plan and publish the share of members
                        whose sleep or activity improved after 90 days.
tools ................. CSV tables with a source URL on every row · JavaScript on Node for
                        the derived rates · D3.js for the first dashboard · React and SVG
                        for the charts on this page

THE QUESTION

the client ............ Oura’s leadership. Oura postponed its IPO on September 29, 2026,
                        with 5.7 million paid members and 90% revenue growth expected for
                        fiscal 2026. Whoop is the comparison, a band sold only with a
                        membership, with more than 2.5 million members.
the decision they face
                        What should Oura build and report so that tracking turns into a
                        lasting change in how members sleep and move?

THE DATA, 2 TABLES FROM 39 SOURCES

[01] metrics.csv ................................................................... 74 rows
     /studies/oura-and-whoop/data/metrics.csv
     Every figure in the study, one per row. It covers growth at Oura, Whoop and Garmin, US
     surveys of wearable use and activity, trial results on activity and sleep, and three
     Duolingo rows that tie back to my streaks study.
     where it came from
                        Press coverage of Oura’s S-1, company press releases, Garmin’s SEC
                        8-K filings, Pew, the HINTS and NHIS surveys, and peer-reviewed
                        meta-analyses.
     why i chose it ... Each figure has an ID and a source URL, so the code and a reader can
                        go to the exact row.
     what it cannot tell us
                        What happens to one person. The survey rows are population totals,
                        and the trial rows are results I took from published papers. The
                        Oura rows cite press coverage of the S-1, and none cites the filing
                        directly.

[02] variables.csv .................................................................. 6 rows
     /studies/oura-and-whoop/data/variables.csv
     Six product features scored 0 to 2 for Oura, Whoop, Apple Watch, Fitbit and Garmin.
     where it came from
                        My own coding from product pages and press releases as of October
                        2026, with a link to the research behind each feature.
     why i chose it ... It puts Oura next to Whoop feature by feature. Oura totals 7 of 12
                        and Whoop 11, and the options aim at the gaps.
     what it cannot tell us
                        Stand as measurement. The scores are judgment, and each row links
                        its research so a reader can disagree. The table holds no URL for
                        the product pages I read.

  # The 39 sources behind metrics.csv
  metrics.csv holds figures from 39 sources. Each one is listed with the rows it supplies
  and what they cover. 19 of them carry figures a company reported about itself.

  - Oura S-1 via BeInCrypto
    3 rows · growth
    A company’s own figures
  - Oura S-1 via Healthcare Dive
    1 row · growth
    A company’s own figures
  - Oura S-1 via TechRepublic
    3 rows · growth
    A company’s own figures
  - Oura press release, Business Wire
    2 rows · growth
    A company’s own figures
  - Oura S-1 via EBC
    4 rows · growth, engagement
    A company’s own figures
  - Fierce Healthcare
    1 row · growth
    A company’s own figures
  - Oura S-1 via SGB Media
    1 row · engagement
    A company’s own figures
  - Oura S-1 via IPO Scoop
    1 row · engagement
    A company’s own figures
  - MedTech Dive
    1 row · valuation
  - Forbes Australia (Reuters calculation)
    1 row · valuation
  - Front Office Sports
    1 row · valuation
  - Digital Health News
    1 row · pricing
    A company’s own figures
  - NPR via WUNC
    1 row · engagement
    A company’s own figures
  - Oura press release via Silicon UK
    1 row · engagement
    A company’s own figures
  - Bloomberg
    2 rows · growth
    A company’s own figures
  - Dealroom
    3 rows · growth, valuation
    1 of 3 rows are a company’s own figures
  - Sacra
    1 row · pricing
    A company’s own figures
  - Garmin 8-K Ex. 99.1, FY2024 results
    2 rows · growth
    A company’s own figures
  - Garmin 8-K Ex. 99.1, FY2025 results
    1 row · growth
    A company’s own figures
  - Garmin 8-K, FY2025 results
    1 row · growth
    A company’s own figures
  - Tom's Guide
    1 row · pricing
    A company’s own figures
  - Pew Research Center
    3 rows · wearable use
  - HINTS via Pedroso et al. 2026
    6 rows · wearable use
  - HINTS 6 via JMIR 2025
    1 row · wearable use
  - Endeavour Partners via MobiHealthNews
    1 row · abandonment
  - Endeavour Partners via NBC News
    1 row · abandonment
  - Gartner via arXiv 1904.07986
    1 row · abandonment
  - NHIS via Healthy People 2030 PA-02
    2 rows · activity guideline
  - NCHS Data Brief 555
    1 row · activity guideline
  - Ferguson et al. 2022, Lancet Digital Health
    3 rows · trial outcomes
  - Ferguson et al. 2022 via Patient Care
    3 rows · trial outcomes
  - Monninghoff et al. 2021, JMIR
    6 rows · effects after a program ends
  - Brickwood et al. 2019, JMIR mHealth
    4 rows · tracker alone and with a program
  - JOSPT 2026 meta-analysis
    1 row · trial outcomes
  - Lai et al. 2022, Nursing & Health Sciences
    1 row · sleep
  - Zhu et al. 2026, JMIR
    1 row · sleep
  - Comas et al., RCT with actigraphy
    1 row · sleep
  - Hartman et al. 2022, JMIR mHealth
    2 rows · tracker alone and with a program
  - Duolingo Q2 2026 shareholder letter
    3 rows · Duolingo tie-in
    A company’s own figures

THE PROCESS

[01] One row per figure
     Each figure went into a row of its own with a source name, a URL, the date I retrieved
     it and a flag for whether the company reported it. That came to 74 rows in metrics.csv
     from 39 source pages.

[02] Parse
     51 of the 74 rows have a comma inside a field, such as “Met aerobic physical activity
     guideline, age-adjusted”. Both files also use CRLF line endings. The parser reads
     quoted fields cell by cell and drops the carriage returns.

[03] Join
     Wearable use comes from HINTS and the activity guideline comes from NHIS. I joined the
     two on year. Both cover 2020 and 2024, and only HINTS has a 2022 figure.

[04] Assumptions
     Some sources gave a figure in words. Whoop’s member count was “more than 2.5M” and went
     in as 2.5. Oura’s share of first-time wearable buyers was “about a third” and went in
     as 33. Rows M01 to M03, the umbrella review’s extra steps and minutes a day, are marked
     approximate. The HINTS abstract gives daily use without naming its base. The table
     reads it as a share of all adults, so daily use stays out of the findings on this page.

[05] Check
     Oura’s nine-month revenue shows up in several press reports, so I checked it two ways.
     Hardware plus membership comes to $1,214.5 million against $1,210 million reported.
     Fiscal 2025 plus the nine-month change gives $1,420.3 million for the trailing year
     against $1,430 million reported. The larger gap is 0.7%, which fits rounding in the
     coverage.

  # One year before and after the join.
  - Before, three rows of metrics.csv (six of 12 columns shown)
  - After, one row per year
  The first two rows are HINTS and the third is NHIS. The comma inside the third metric name
  is why the parser reads quoted fields.

  # The code for the key steps
  - The parser, which handles commas inside quoted fields and CRLF line endings.
    derive.mjs ........ /studies/oura-and-whoop/derive.mjs
  - The join between the HINTS rows and the NHIS rows, by year.
    derive.mjs ........ /studies/oura-and-whoop/derive.mjs
  - The headline changes and shares.
    derive.mjs ........ /studies/oura-and-whoop/derive.mjs

  # Dead ends
  google trends ....... I left Google Trends out because the research workspace could not
                        reach it.
  no 2022 point for activity
                        The Healthy People page has no 2022 value for the aerobic guideline.
                        The 2022 wearable figure of 36.36% comes from a separate analysis of
                        the same HINTS survey, so the comparison runs from 2020 to 2024.

THE 3 FINDINGS THAT CHANGE THE DECISION

[01] +0.1 points · Change in adults meeting the aerobic guideline, 2020 to 2024
     From 2020 to 2024 the share of US adults using a wearable rose from 30.2% to 41.1%, and
     the share meeting the aerobic activity guideline went from 47.9% to 48.0%.
     dataset .......... metrics.csv
     query ............ derive.mjs, trend()

     # Wearable use rose from 30.2% to 41.1%. The share meeting the activity guideline moved
       0.1 points
     Wearable use is from HINTS. Meeting the aerobic guideline is from NHIS, age-adjusted.
     They are two different surveys, and population totals cannot show what happens to one
     user. NHIS has no 2022 value on the Healthy People page, so each line has two points.
     year ............. Share of US adults (%)
     meet the aerobic guideline
                        2020 47.9, 2024 48.0
     use a wearable ... 2020 30.2, 2024 41.1
     source ........... metrics.csv, derive.mjs, trend()

[02] 54% · Share of the end-of-program walking effect left at long follow-up
     In a meta-analysis of mobile health activity trials, only 54% of the walking effect was
     left at follow-ups more than six months after a program ended.
     dataset .......... metrics.csv
     query ............ derive.mjs, headline()

     # Only 54% of the walking effect is left after a program ends
     Standardized mean difference (SMD) against control, pooled in one meta-analysis
     (Monninghoff et al. 2021, JMIR). Around 0.2 is small and 0.5 is medium. Few trials
     report long follow-up, so the later bars rest on less data.
     When the effect was measured ..................... Walking effect against control (SMD)
     End of program ................................................................... 0.46
       Moderate-to-vigorous activity effect (SMD): 0.28 · Trials behind it: 117 mHealth
       trials
     Up to 6 months after ............................................................. 0.26
       Moderate-to-vigorous activity effect (SMD): 0.20 · Trials behind it: 33 trials with
       short follow-up
     More than 6 months after ......................................................... 0.25
       Moderate-to-vigorous activity effect (SMD): 0.19 · Trials behind it: 8 trials with
       long follow-up
     source ........... metrics.csv, derive.mjs, fade()

[03] 1.9x · Activity gain with a program around the tracker over the tracker alone, 0.33
     against 0.17 SMD
     Trials that put a program around the tracker raised moderate-to-vigorous activity about
     twice as much as the tracker alone. The tracker-alone result was too small to rule out
     chance.
     dataset .......... metrics.csv
     query ............ derive.mjs, design()

     # A program around the tracker moved activity about twice as much as the tracker alone
     Subgroups of one review of consumer trackers (Brickwood et al. 2019, JMIR mHealth).
     Each group was compared with a control group, and the tracker-alone result was not
     statistically significant. SMD is the standardized mean difference, where around 0.2 is
     small and 0.5 is medium. In the review a program meant added support such as counseling
     or financial incentives. Trackers that came with app messages or emails counted as
     tracker alone.
     Outcome and design ....................................... Effect against control (SMD)
     MVPA, tracker plus program ....................................................... 0.33
       Source row: M16 · Note in the table: None
     MVPA, tracker alone .............................................................. 0.17
       Source row: M15 · Note in the table: Not significant (P = .05)
     Daily steps, tracker plus program ................................................ 0.26
       Source row: M14 · Note in the table: None
     Daily steps, tracker alone ....................................................... 0.20
       Source row: M13 · Note in the table: 28 RCTs, 3,646 adults
     source ........... metrics.csv, derive.mjs, design()

MY RECOMMENDATION

  Turn Advisor into a weekly plan, and publish how many members sleep or move more after 90
  days.

[A] Turn Advisor into a weekly plan
     Each week Advisor picks one behavior from the member’s own sleep and Readiness data. It
     sets a target for that week and checks in midway.
     evidence ......... Findings 2 and 3. Trials that put a program around the tracker
                        raised moderate-to-vigorous activity about twice as much as the
                        tracker alone, and the walking effect fades once a program ends. On
                        my 0-to-2 scale for coaching, Oura scores 1 and Whoop and Fitbit
                        score 2.
     main risk ........ That result comes from subgroups of one review, and the
                        tracker-alone result beside it was not significant. The programs in
                        that review added support such as counseling or financial
                        incentives. App messages counted as tracker alone, so an Advisor
                        plan may land nearer the tracker-alone result.

[B] Publish a behavior-change number
     Report the share of members whose sleep time or active minutes improved after 90 days,
     beside the 85% retention figure.
     evidence ......... Finding 1 and Oura’s own funnel. Oura reports 3.6 million rings sold
                        in a year, 94% of activations turning into paid members, 85% of paid
                        members kept for a year and a median 23 hours a day of wear. Its
                        closest figure to an outcome is a survey where 56% of Advisor users
                        said it helped them act.
     main risk ........ Oura would report the number itself. 19 of the 22 Oura rows in this
                        study already come from the company, and the 56% survey has no
                        outcome data behind it.

  - Two findings back the weekly plan. A program around the tracker moved activity about
    twice as much as the tracker alone, and the effect faded once the program ended, so the
    plan has to keep running.
  - The 90-day number tells Oura and its members whether the plan works. Today the closest
    thing Oura has is a survey where members said Advisor helped.
  - That number should go out with its method, since Oura would be grading itself.

LIMITS AND NEXT STEPS

  # What the data cannot support
  - Population totals cannot show what happens to one user, and wearable use and the
    activity guideline come from two different surveys.
  - No row here compares people who pay a subscription with people who do not, and none of
    the trial rows names Oura or Whoop.
  - The Oura rows cite press coverage of the S-1. I found no behavior outcome in that
    coverage, which is a weaker claim than saying the filing has none.
  - 31 of the 74 rows in metrics.csv are flagged as reported by the company they describe,
    including every Oura engagement figure.
  - Finding 2 compares different sets of trials. The end-of-program effect pools 117 mHealth
    trials, and the later points rest on 33 trials with short follow-up and 8 trials with
    long follow-up.
  - The feature scores are my own judgment.
  - Every row was retrieved on October 31, 2026, so nothing after that date is here.

  # What I would test with more access
  - With HINTS microdata and survey weights I would link wearable use and activity for the
    same person.
  - With Oura’s own data I would measure the number option B asks for, the share of members
    whose sleep time or active minutes improved after 90 days.
  - I would add Google Trends search interest, which I could not reach, and source the Oura
    rows from the S-1 itself.

TL;DR

studied ............... Whether paying for a wearable changes how people live, read from US
                        surveys and activity trials.
found ................. From 2020 to 2024, wearable use rose from 30.2% to 41.1% and adults
                        meeting the activity guideline went from 47.9% to 48.0%.
  # by the numbers
  +0.1 points ......... Change in adults meeting the guideline
  54% ................. Of the walking effect left at long follow-up
  85% ................. Paid Oura members kept for a year
the catch ............. Wearable use and the activity guideline come from two different
                        surveys, so neither shows what one user did.
next .................. With person-level HINTS survey data, link wearable use and activity
                        for the same person.

# end of /machine/oura-and-whoop. andrew.leng.ly@gmail.com · leave machine mode